Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method

PURPOSE: This study aimed to formulate an orally disintegrating tablet (ODT) containing both baclofen and meloxicam together for treating osteoarthritis. METHODS: Direct compression method was used to prepare ODTs using three types of co-processed excipients (Prosolv ODT G2(®), F-melt(®), and Pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelmonem, Rehab, Abdellatif, Menna M, Al-Samadi, Inas Essam Ibrahim, El-Nabarawi, Mohamed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530526/
https://www.ncbi.nlm.nih.gov/pubmed/34690500
http://dx.doi.org/10.2147/DDDT.S327193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530526/
https://www.ncbi.nlm.nih.gov/pubmed/34690500
http://dx.doi.org/10.2147/DDDT.S327193

Ejemplares similares